REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
July 25, 2023
FROM
WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center
SUBJECT
Title
Non-Financial Agreement with the University of Cincinnati for a Study
End
RECOMMENDATION(S)
Recommendation
Approve non-financial Institutional Review Board Authorization Agreement with the University of Cincinnati, for participation in the ASPIRE: Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery study, effective upon execution and continuing until terminated by either party.
(Presenter: William L. Gilbert, Director, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost) as the Authorization Agreement with the University of Cincinnati (University) is non-financial in nature.
BACKGROUND INFORMATION
The Institutional Review Board Authorization Agreement (Agreement) with the University is the authorization agreement for participation in the ASPIRE: Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery study (Study), and will enable the University’s Institutional Review Board (IRB) to serve as the central IRB for the Study at Arrowhead Regional Medical Center (ARMC).
On July 14, 2020 (Item No. 11), the Board of Supervisors approved Contract No. 20-572 with the University for ARMC to participate in the Study and accept revenue as a result of the Study for the period of July 14, 2020 through April 30, 2024. The Study is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent intracerebral hemorrhage and high-risk non-valvular atrial fibrillation (AF), which is an AF that is not caused by a problem with a heart valve.
Under federal law, clinical trials and certain research studies in healthcare facilities involving human subjects must be approved and supervised by each facility’s IRB to ensure the protection of those subjects. However, in large scale studies, the primary facility involved in the study may serve as the central IRB for the study to ensure that the study is conducted consistently at all study sites. In order to do this and comply with federal law, facilities involved in those studies must enter into an authorization agreement that authorizes the study site to rely on the central IRB for review, approval, and continuing oversight of the study in lieu of its own IRB. In the authorization agreement, the review performed by the central IRB will meet the human subject protection requirements of the local facility’s Federalwide Assurance, which is the assurance of compliance with the United States federal regulations for the protection of human subjects in research. The IRB Agreement with the University is the authorization agreement discussed above with respect to the Study, and will enable the University’s IRB to serve as the central IRB for the Study at ARMC.
The term of the Agreement commences on the date of the last signature and continues until terminated by either party with 30 days written notice. ARMC recommends approval of the Agreement to comply with applicable federal law governing the Study at ARMC. The Study will provide for the health and safety of county residents by testing the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular AF.
PROCUREMENT
Not applicable.
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Charles Phan, Deputy County Counsel, 387-5455) on July 12, 2023; ARMC Finance (Chen Wu, Finance Budget Officer, 580-3165) on June 29, 2023; Finance (Jenny Yang, Administrative Analyst, 387-4884) on June 29, 2023; and County Finance and Administration (Valerie Clay, Deputy Executive Officer, 387-5423) on June 30, 2023.